UPDATE : Monday, May 25, 2020
Chinese drugmaker Mebo establishes branch in Korea
Mebo Group, a Chinese firm specializing in regenerative medicine, has estab...
by Lee Han-soo  |  2020-01-06 14:40
[New Year Special] Boryung, Hanmi in fierce battle to fill ranitidine void
After the regulator kicked ranitidine and nizatidine out of the market due ...
by Jeong Sae-im  |  2020-01-03 17:56
Bukwang, Sanofi Aventis Korea to co-promote hypertension med
Bukwang Pharmaceutical said that it would promote and market Aprovel and Co...
by Lee Han-soo  |  2020-01-03 17:55
Daewoong launches oral typhoid fever vaccine
Daewoong Pharmaceutical said that it has launched Vivotif, an oral typhoid ...
by Lee Han-soo  |  2020-01-03 17:55
[New Year Special] Rise of digital therapeutics to change healthcare scene for good
If a person gets sick, he or she visits a doctor, gets a prescription, take...
by Lee Han-soo  |  2020-01-03 14:57
SK Bioscience’s influenza vaccine nabs WHO certification
SK Bioscience said that the World Health Organization (WHO) has granted pre...
by Lee Han-soo  |  2020-01-03 14:14
Daewoong to kick off P3 trial of Nabota in China
Daewoong Pharmaceutical said Tuesday that it held a meeting with Chinese re...
by Lee Han-soo  |  2020-01-02 17:36
FDA OKs Huons' generic of topic anesthetic injection
Huons said that the U.S. Food and Drug Administration has approved the comp...
by Lee Han-soo  |  2020-01-02 14:30
Medytox launches liquid-type BTX 'Innotox 100 unit' in local market
Medytox said that the Ministry of Food and Drug Safety has approved to sell...
by Lee Han-soo  |  2020-01-02 12:12
Korean biopharmaceuticals competitively move abroad to expand global presence
Local pharmaceutical companies are actively advancing to overseas markets. ...
by Jeong Sae-im  |  2019-12-30 17:20
Migraine drug market heats up with Ubrelvy’s arrival
After Lilly’s acute migraine drug Reyvow (ingredient: lasmiditan) obtained ...
by Kim Yun-mi  |  2019-12-27 11:57
Local biopharmaceutical companies suffer from unsatisfactory P3 global trial results
Many of the local biopharmaceutical companies that attracted high expectati...
by Jeong Sae-im  |  2019-12-27 07:06
Dupixent to get coverage from January
Sanofi’s new biologic agent Dupixent (ingredient: dupilumab) for severe ato...
by Kim Yun-mi  |  2019-12-24 15:40
‘Korea still slow to expand benefit for new drugs’
Avi Ben-Shoshan, chairman of the Korea Research-based Pharma Industry Assoc...
by Kim Yun-mi  |  2019-12-24 15:37
Shanghai Ocumension to market Huonland's HA eyedrop
Huonland, a joint venture between Huons and Beijing Northland, said that it...
by Lee Han-soo  |  2019-12-23 15:43
Alteogen's growth hormone deficiency treatment wins orphan drug status
Alteogen said that the U.S. Food and Drug Administration has granted an orp...
by Lee Han-soo  |  2019-12-23 14:46
Daewoong partners with Aeon Biopharma to tap therapeutic BTX market
Daewoong Pharmaceutical said that it has agreed with Aeon Biopharma to expa...
by Lee Han-soo  |  2019-12-23 11:23
Successful drug development – getting it right from the start
When it comes to successful drug development, today’s pharma and biotech co...
by Lee Han-soo  |  2019-12-20 16:30
Pfizer wins Champix patent suit against 20 local generics makers
Pfizer won a patent lawsuit against local drugmakers over its antismoking d...
by Jeong Sae-im  |  2019-12-20 16:28
Chemas to research anticancer treatment in Germany
Chemas, a local pharmaceutical company, said that it has completed its prep...
by Lee Han-soo  |  2019-12-20 15:18
Back to Top